| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |